StockNews.com Downgrades PTC Therapeutics (NASDAQ:PTCT) to Hold
StockNews.com lowered shares of PTC Therapeutics (NASDAQ:PTCT – Free Report) from a buy rating to a hold rating in a research note published on Monday morning. Several other analysts have also recently issued reports on PTCT. Morgan Stanley raised PTC Therapeutics from an “equal weight” rating to an “overweight” rating and raised their target price […]
StockNews.com lowered shares of PTC Therapeutics (NASDAQ:PTCT – Free Report) from a buy rating to a hold rating in a research note published on Monday morning. Several other analysts have also recently issued reports on PTCT. Morgan Stanley raised PTC Therapeutics from an “equal weight” rating to an “overweight” rating and raised their target price […]
